| Literature DB >> 29900351 |
Vivek Verma1, Renu Arora2, Rakesh Singh Dhanda3, Rajni Gaind4, Manisha Yadav1.
Abstract
Urinary tract infections (UTI) are a major cause of morbidity, affecting at least four million women worldwide, 65-75% of these infections are caused by Uropathogenic Escherichia coli (UPEC) (Foxman, 2010) [1]. Repertoire of virulence factors carried by UPEC provides the ability to precede urinary tract and additionally they provoke pro-inflammatory responses (Cirl et al., 2008; Verma et al., 2016) [2], [3]. In context to UPEC infected UTI patients, the levels of pro-inflammatory cytokine IL-1β and enzymatic antioxidant nitric oxide (NO) have not been reported worldwide till date, including India. In this data article, we report for the first time the levels of IL-1β and nitric oxide in the plasma of UPEC infected UTI patients. Data includes a profile of pro-inflammatory cytokine IL-1β and NO in the plasma of the confirmed UPEC infected UTI patients (N = 30) versus healthy controls (N = 40) from the present pilot study. The levels of IL-1β in plasma were significantly higher (p < 0.0001) in patients (252.3 ± 6.49 pg/ml) as compared to healthy controls (127.6 ± 3.98 pg/ml), whereas plasma levels of NO were significantly lower (p < 0.0001) in UPEC infected UTI patients (60.29 ± 1.1 μM) as compared to healthy controls (106.3 ± 8.75 μM).Entities:
Keywords: Interleukin-1β; Nitric oxide; Uropathogenic Escherichia coli
Year: 2018 PMID: 29900351 PMCID: PMC5997911 DOI: 10.1016/j.dib.2018.05.058
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1(A) Graph represents the grouped scattered plot of Plasma levels of pro-inflammatory cytokine IL-1β (pg/ml) in the UTI patient versus Control group. P value < 0.0001; (B) Graph represents the grouped scattered plot of NO levels (μM) in the UTI patient versus Control group. P value < 0.0001.
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |